pharma news today glp-1 obesity drugs Agonists Weight Loss Market Report, 2025-2030 WHO GLP-1 Treatments: WHO Endorses

This innovation results in an elimination half-life of approximately 90 h (~4 days), supporting a once-weekly SC dosing regimen

The strongest signals were seen in epigenetic measures linked to inflammation, brain, heart, blood, kidney, liver and metabolic health, suggesting that the drug may influence aging-related biology across multiple body systems

These women didnt intend to get pregnant while taking the medicationit happened accidentally

Oats, beans, lentils, apples, pears, and many vegetables and berries contain the kind of fiber your gut bacteria ferment into short-chain fatty acids

Moreover, existing data indicate that single-target GLP-1RAs such as SEMA and liraglutide show promising capabilities for fibrosis improvement, and the initial success of the dual agonist tirzepatide suggests potential benefits of dose titration therapy in the monotherapy management of MASLD